NCT05583136

Brief Summary

Developmental dyslexia (DD) is a multifactorial disorder that hampers the education of about 10% of individuals across cultures and is associated to both phonological and visual deficits. The latter have been linked to a deficit in the magnocellular-dorsal (M-D) visual stream, that has a critical role in guiding the activity of ventral visual stream areas where letters identity is extracted. Here, we will test the efficacy of transcranial alternate current stimulation (tACS) of the M-D stream combined with reading trainings in adult participants with DD, assessing the neurophysiological underpinnings of these new trainings with EEG and fMRI/DTI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 14, 2021

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 7, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 17, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 23, 2024

Completed
Last Updated

January 27, 2025

Status Verified

October 1, 2022

Enrollment Period

3 years

First QC Date

October 7, 2022

Last Update Submit

January 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reading score

    Text, word and pseudowords reading score

    Pre-training, 1-7 days post-training, follow-up at 1 and 6 months

Study Arms (3)

Group DD1

EXPERIMENTAL

tACS + visuo-attentional training

Device: Parietal tACS combined with visuo-attentional training

Group DD2

ACTIVE COMPARATOR

Sham (placebo) tACS + visuo-attentional training

Device: Sham (placebo) tACS combined with visuo-attentional training

Group DD3

ACTIVE COMPARATOR

Sham (placebo) tACS + phonics training

Device: Sham (placebo) tACS combined with phonics training

Interventions

Parietal tACS combined with visuo-attentional training

Group DD1

Sham (placebo) tACS combined with visuo-attentional training

Group DD2

Sham (placebo) tACS combined with phonics training

Group DD3

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patient (age between 18 and 35)
  • Official Diagnosis of Developmental Dyslexia (DD)
  • Normal or corrected-to-normal vision and hearing
  • Normal motor skills

You may not qualify if:

  • Participants that cannot sign the consent form
  • Participants unable to read or understand and correctly complete the procedures foreseen by the study
  • Participants with a diagnosis or personal history of epilepsy or patients with a positive family history of epilepsy
  • Pregnant or breastfeeding patients
  • Participants with major psychiatric or neurological disorders and/or currently in psychopharmacological treatments.
  • Participants with metal implants in the brain, pacemakers, brain stimulators, cochlear implants.
  • Participants with claustrophobia (only for fMRI)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Luca Ronconi

Milan, Italy, 20132, Italy

Location

MeSH Terms

Conditions

Dyslexia

Condition Hierarchy (Ancestors)

Language DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSpecific Learning DisorderLearning DisabilitiesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 7, 2022

First Posted

October 17, 2022

Study Start

December 14, 2021

Primary Completion

December 23, 2024

Study Completion

December 23, 2024

Last Updated

January 27, 2025

Record last verified: 2022-10

Locations